In short: Purisaki patches use a three-layer transdermal delivery system that releases 13 botanical ingredients steadily through the skin over 8 hours — achieving more consistent blood concentrations than oral supplements while completely bypassing the digestive system.
Why Oral Berberine Has Limitations
Berberine is a large polar molecule with inherently poor intestinal absorption. Research on berberine pharmacokinetics indexed at PubMed shows oral absorption can be as low as 5% in some studies — the unabsorbed fraction remaining in the GI tract causes the nausea, cramping, and diarrhea that affect many users. The portion that does absorb undergoes first-pass liver metabolism, further reducing active compound reaching target tissues. This drives the need for higher oral doses, which worsens GI side effects.
The Three-Layer Purisaki Delivery System
Protective Biodegradable Backing
Each patch is individually sealed in a foil pouch that protects all 13 botanical ingredients from moisture, air, and UV degradation until the moment of application. When you open the pouch, every ingredient is at full potency.
Controlled-Release Botanical Matrix
The botanical formula is embedded in a precision-engineered matrix that meters the release rate throughout the 8-hour wear period. Rather than the concentration spike of a dissolved capsule, the matrix maintains a consistent, gradual release — producing the steady botanical support that multiple-dose oral regimens attempt but often fail to achieve in practice.
BreathFlex Skin-Contact Layer
Purisaki's proprietary adhesion layer is breathable, sweat-resistant, and gentle. It maintains reliable contact through physical activity and daily wear while being comfortable for rotation across multiple skin sites. Full ingredient guide →
Berberine's AMPK Mechanism
Berberine activates AMPK (AMP-activated protein kinase) — the cellular energy sensor that acts as the body's metabolic master switch. AMPK activation drives: enhanced glucose uptake into muscle cells, increased fat oxidation, reduced hepatic glucose production, and improved insulin receptor sensitivity. Research from the NCBI confirms these effects across multiple tissue types. Fucoxanthin activates UCP1 from a different pathway. Green tea's EGCG activates thermogenic signaling through AMPK-independent routes. Together, the three primary actives provide multi-pathway metabolic support that no single ingredient achieves alone. Full benefits breakdown →